Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleJS212 Combination Therapies in Metastatic Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT07503756 - No phaseTaking peopleRectal Cancer Neoadjuvant Therapy-Real World Study
- Where
- Beijing
- Age
- 18 years and over
- People
- 869
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07566559 - Phase 1/2Taking peopleA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 502
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT07283367 - Phase 1/2Taking peopleLow Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Fudan University
See details and how to joinNCT07561060 - Phase 2Taking peopleA Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Fudan University
See details and how to joinNCT07562490 - Phase 2Taking peopleRandomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 340
- Run by
- Fudan University
See details and how to joinNCT07562503 - Phase 2Taking peopleRandomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 80
- Run by
- Fudan University
See details and how to joinNCT07562659 - Phase 2Taking peopleRandomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 340
- Run by
- Fudan University
See details and how to joinNCT07562711 - Phase 3Taking peopleNeoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 556
- Run by
- Sun Yat-sen University
See details and how to joinNCT07528209 - Phase 2Taking peopleNew Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
- Where
- Changchun
- Age
- 18 years to 75 years
- People
- 30
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07559760 - Phase 2Taking peopleFruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 62
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06356584 - Early phase 1Enrolling by invitationMRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
- Where
- Wenzhou
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06434376 - Phase 2Taking peopleRadiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 88
- Run by
- Sun Yat-sen University
See details and how to joinNCT06911684 - Phase 2Not yet taking people in ChinaOncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 114
- Run by
- Jun Huang
See details and how to joinNCT07381309 - No phaseTaking peopleWatch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 47
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT04643041 - Phase 2Taking peopleSafety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 17
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06002789 - Phase 1Not yet taking people in ChinaLDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
- Where
- Chongqing
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07453875 - No phaseTaking peopleSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years and over
- People
- 26
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552467 - Phase 2Taking peopleNode-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
- Where
- Jinhua
- Age
- 18 years to 75 years
- People
- 37
- Run by
- Jinhua Central Hospital
See details and how to joinNCT06204094 - Phase 1/2Taking peopleA Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Nanchang, Shanghai, Taizhou, Wuhan
- Age
- 18 years to 75 years
- People
- 440 worldwide
- Run by
- Tyligand Pharmaceuticals (Suzhou) Limited
See details and how to joinNCT06385925 - No phaseTaking peoplePredicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
- Where
- Guangzhou, Zhuhai
- Age
- 18 years and over
- People
- 1,700
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT05523245 - No phaseTaking peopleA Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI
- Where
- Guangzhou, Maoming
- People
- 300
- Run by
- Peiyi Xie
See details and how to joinNCT07381322 - Phase 2Not yet taking people in ChinaImprovement Effect of Dexamethasone Enema for Acute Radiation-induced Rectal Injury
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07548736 - Phase 3Taking peopleNeoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 386
- Run by
- Akeso
See details and how to joinNCT07412613 - Phase 2Not yet taking people in ChinaA Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer
- Where
- Chongqing
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT07543848